However, pretreatment with kaempferol decreases myeloperoxidase (MPO) activity and the release of proinflammatory cytokines, including TNF-α, thereby decreasing the kidney infiltration of leukocytes and alleviating kidney damage. The gene discussed is MPO; the disease is Nephropathy.